{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-125026","form_type":"8-K","ticker":"COLL","cik":"0001267565","company_name":"COLLEGIUM PHARMACEUTICAL, INC","filed_at":"2025-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.004675+00:00","generated_at":"2026-05-16T11:57:43.811400+00:00","sec_items":["1.01","1.02","3.02","7.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Collegium closes $980M syndicated credit facility, repays Pharmakon loan","bullets":["$980M total facility: $580M term loan, $300M delayed draw, $100M revolver; matures 2030.","Initial term loan used to repay ~$581M of existing Pharmakon debt; previous facility was $646M.","Interest rate SOFR + 2.75%–3.75% (initial 2.75%), expected to deliver meaningful annualized interest savings.","Delayed draw and revolver undrawn at close; earmarked for general corporate purposes and M&A.","Truist Bank administrative agent; bank syndicate includes Citizens, MUFG, Fifth Third, Huntington, U.S. Bank."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-125026","json":"https://secwatch.observer/filing/0001104659-25-125026.json","markdown":"https://secwatch.observer/filing/0001104659-25-125026.md","text":"https://secwatch.observer/filing/0001104659-25-125026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267565/000110465925125026/0001104659-25-125026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267565/000110465925125026/tm2534421d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:57:43.811400+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"45bcc0768fe80fa0f6ad59f0b0dadff76ad249d2","claim":"COLLEGIUM PHARMACEUTICAL, INC entered into Credit Agreement with Truist Bank, as administrative agent valued at $580,000,000 term loan, $300,000,000 of delayed draw term loan commitments, and a $100,000,000 revol (effective 2025-12-23).","evidence_excerpt":"On December 23, 2025, Collegium Pharmaceutical, Inc. (the “Company”) entered into a Credit Agreement by and among the Company, the lenders from time to time party thereto and Truist Bank, as administrative agent (the “Credit Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267565/000110465925125026/0001104659-25-125026-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Truist Bank, as administrative agent"},{"label":"Value","value":"$580,000,000 term loan, $300,000,000 of delayed draw term loan commitments, and a $100,000,000 revol"},{"label":"Effective","value":"2025-12-23"}],"fact_type":"material_agreement"},{"claim_id":"470451fcaf42038a34ec3482b501040a47ac7983","claim":"COLLEGIUM PHARMACEUTICAL, INC terminated Second Amended and Restated Loan Agreement with Biopharma Credit PLC, as collateral agent (effective 2025-12-23).","evidence_excerpt":"On December 23, 2025, in connection with its entry into the Credit Agreement, the Company repaid in full all obligations outstanding under the Existing Credit Agreement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267565/000110465925125026/0001104659-25-125026-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Biopharma Credit PLC, as collateral agent"},{"label":"Effective","value":"2025-12-23"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}